期刊文献+

早期子宫内膜癌的外科治疗 被引量:9

Surgical Treatment for Early Stage Endometrial Cancer
下载PDF
导出
摘要 子宫内膜癌是最常见的妇科恶性肿瘤之一。最近的前瞻性研究表明,随着腹腔镜手术技术的进步,对子宫内膜癌患者进行微创手术治疗已经实现。标准的子宫内膜癌手术治疗为包括全子宫和双侧输卵管、卵巢在内的切除手术。最新发展的机器人手术平台为要求甚高的传统腹腔镜手术提供了可选的高级技术,并能使更多的子宫内膜癌患者采用微创手术进行治疗。早期子宫内膜癌的外科手术治疗中联合腹、盆腔淋巴结清扫的分期手术以及保留生育功能的治疗对患者的临床效果一直是热点话题。关于包括淋巴结清扫在内的全面分期手术对早期子宫内膜癌患者的益处仍存在争议。对目前早期子宫内膜癌的定义、预后因素及最新的手术治疗进展和一些正在被纳入的新技术进行综述。 Endometrial carcinoma is one of the most common gynecologic malignant tumor. Recent prospective data showed that, with the progress of laparoscopic operation techniques, minimally invasive surgery in patients with endometrial cancer treatment have been implemented. It is widely agreed that for early endometrial cancer standard operation treatment including operation excise uterus and bilateral tubal ovarian. Latest development of robotic surgical platform can offer optional advanced technologies for traditional laparoscopic surgery which demanding more, and can increase the number of patients with endometrial cancer treatment using minimally invasive surgery. The surgical treatment of early endometrial carcinoma combined abdominal and pelvic lymph node cleaning staging surgery as well as keep the reproductive function of patients with clinical effect has been a hot topic. The benefits of comprehensive staging operation, including lymph node cleaning in patients with early endometrial cancer is still controversial. This paper will review the current progress in the definition of early endometrial cancer, prognostic factors and new operation treatment and some are being incorporated into the new technology.
出处 《国际妇产科学杂志》 CAS 2015年第6期612-615,共4页 Journal of International Obstetrics and Gynecology
关键词 腹腔镜 子宫内膜肿瘤 外科手术 微创性 Laparoscopes Endometrial neoplasms Carcinoma Surgical procedures minimally invasive
  • 相关文献

参考文献21

  • 1Siegel R,Naishadham D,Jemal A. Cancer statistics,2013 [J]. CA Cancer J Clin, 2013,63( 1 ) : 11-30.
  • 2Seagle BL, Dawson M, Samuelson R,et al. Feasibility,Sensitivity, and Specificity of Postprocedure Peritoneal Cytology [J]. Reprod Sci, 2015,22(7 ) : 808-813.
  • 3Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium[J]. Int J Gynaecol Obstet, 2009,105 (2) : 103-104.
  • 4Clements AE,Tierney B J, Cohn DE, et al. Is selective lymphadenec- tomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer? [J]. Gynecol Oncol,2013,128 (2) : 166- 170.
  • 5Baek MH, Lee SW, Park JY, et al. Feasibility and safety of laparoscopic surgery for obese Korean women with endometrial cancer :long-term results at a single institution [J]. J Korean Med Sci, 2014,29 (11 ): 1536-1543.
  • 6Wang HL,Ren YF,Yang J,et al. Total laparoscopic hysterectomy versus total abdominal hysterectomy for endometrial cancer:a meta- analysis [J]. Asian Pac J Cancer Prey,2013,14(4) :2515-2519.
  • 7Kfihler C, Klemm P, Schan A,et al. Introduction of transperitoneal lymphadenectomy in a gynecologic oncology center:analysis of 650 laparoscopic pelvic and/or paraaortic transperitoneal lymphadenectomies [J]. Gynecol Oncol, 2004,95 ( 1 ) : 52-61.
  • 8Vogel TJ,Knickerbocker A,Shah CA,et al. An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centers [J]. J Gynecol Oncol, 2015,26( 1 ) : 25-31.
  • 9Einarsson JI,Matteson KA,Schulkin J,et al. Minimally invasive hysterectomies-a survey on attitudes and barriers among practicing gynecologists[J]. J Minim Invasive Gynecol, 2010, 17 (2) : 167-175.
  • 10Chen I,Lisonkova S,Allaire C,et al. Routes of hysterectomy in women with benign uterine disease in the Vancouver Coastal Health and Providence Health Care regions:a retrospective cohort analysis [J]. CMAJ Open, 2014,2(4) : E273-E280.

同被引文献79

  • 1杨佳欣.子宫内膜癌保留生育功能治疗的进展[J].妇产与遗传(电子版),2013,3(4):48-52. 被引量:2
  • 2Chen W,Zheng R,Baade PD,et al. Cancer statistics in China,2015[J].CA Cancer J Clin,2016,66(2):115-132. doi:10.3322/caac.21338.
  • 3Siegel RL,Miller KD,Jemal A. Cancer statistics,2015[J].CACancer J Clin,2015,65(1):5-29. doi:10.3322/caac.21254.
  • 4Morice P,Leary A,Creutzberg C,et al. Endometrial cancer[J].Lancet,2016,387(10023):1094-1108. doi:10.1016/S0140-6736(15)00130-0.
  • 5Kalogera E,Scholler N,Powless C,et al. Correlation of serum HE4with tumor size and myometrial invasion in endometrial cancer[J].Gynecol Oncol,2012,124 (2) :270- 275. doi:10.1016/j.ygyno.2011.10.025.
  • 6Dobrzycka B,Mackowiak- Matejczyk B,Terlikowska KM,et al.Utility of HE4 to identify patients with endometrioid endometrialcancer who may require lymphadenectomy[J]. Adv Med Sci,2015,61(1):23-27. doi:10.1016/j.advms.2015.07.010.
  • 7Bignotti E,Ragnoli M,Zanotti L,et al. Diagnostic and prognostic impactof serum HE4 detection in endometrial carcinoma patients[J]. Br JCancer,2011,104(9):1418-1425. doi:10.1038/bjc.2011.109.
  • 8NCCN. The NCCN uterine neoplasms clinical practice guidelines inoncology.(version2.2016)[EB/OL].(2015-11-20)[2016-04-02].http://www.nccn.org/professionals/ph-ysician_gls/f_guidelines.asp.
  • 9Amant F,Mirza MR,Koskas M,et al. Cancer of the corpus uteri[J].IntJ Gynecol Obstet,2015,131(Suppl 2):S96-S104. doi:10.1016/j.ijgo.2015.06.005.
  • 10Capriglione S,Plotti F,Miranda A,et al. Utility of tumor markerHE4 as prognostic factor in endometrial cancer:a single- centercontrolled study[J].Tumor Biolo,2015,36(6):4151-4156.doi:10.1007/s13277-015-3049-3.

引证文献9

二级引证文献101

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部